September 2025

RHEUMATOLOGY

VAGUS NERVE STIMULATION OFFERS AN INNOVATIVE APPROACH TO RHEUMATOID ARTHRITIS TREATMENT

Eric Ruderman, MD, discusses the recent FDA approval of vagus nerve stimulation for rheumatoid arthritis. The approval was based on the findings from the RESET-RA trial, which involved multiple locations, including Northwestern Medicine. Dr. Ruderman provides insights on the trial, which evaluated a stimulation device in patients who did not respond to conventional therapies. The trial observed significant improvements in disease activity with active stimulation when compared to patients who didn’t receive stimulation.
Northwestern Medicine plans to offer vagus nerve stimulation soon. 
Eric M. Ruderman, MD, Professor of Rheumatology at Northwestern Medicine​

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like